Zhou YL - Search Results

1

Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.

Zhou YL, Zhang W, Gao EL, Dai XX, Yang H, Zhang XH, Wang OC. Zhou YL, et al. Asian Pac J Cancer Prev. 2012;13(4):1267-72. doi: 10.7314/apjcp.2012.13.4.1267. Asian Pac J Cancer Prev. 2012. PMID: 22799316 Free article.

2

Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.

Zhou YL, Gao EL, Zhang W, Yang H, Guo GL, Zhang XH, Wang OC. Zhou YL, et al. World J Surg Oncol. 2012 May 19;10:67. doi: 10.1186/1477-7819-10-67. World J Surg Oncol. 2012. PMID: 22540396 Free PMC article.

3

Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas.

Zhou YL, Liu C, Dai XX, Zhang XH, Wang OC. Zhou YL, et al. Med Oncol. 2012 Dec;29(5):3360-6. doi: 10.1007/s12032-012-0315-8. Epub 2012 Aug 2. Med Oncol. 2012. PMID: 22855362

4

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer.

Zhang W, Gao EL, Zhou YL, Zhai Q, Zou ZY, Guo GL, Chen GR, Zheng HM, Huang GL, Zhang XH. Zhang W, et al. Among authors: zhou yl. World J Surg Oncol. 2012 Dec 8;10:262. doi: 10.1186/1477-7819-10-262. World J Surg Oncol. 2012. PMID: 23216911 Free PMC article.

5

Hashimoto's thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer.

Ye ZQ, Gu DN, Hu HY, Zhou YL, Hu XQ, Zhang XH. Ye ZQ, et al. Among authors: zhou yl. World J Surg Oncol. 2013 Mar 5;11:56. doi: 10.1186/1477-7819-11-56. World J Surg Oncol. 2013. PMID: 23496874 Free PMC article.

6

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients.

Jin L, Chen E, Dong S, Cai Y, Zhang X, Zhou Y, Zeng R, Yang F, Pan C, Liu Y, Wu W, Xing M, Zhang X, Wang O. Jin L, et al. Oncotarget. 2016 Apr 5;7(14):18346-55. doi: 10.18632/oncotarget.7811. Oncotarget. 2016. PMID: 26943032 Free PMC article.

7

Next-generation sequence detects ARAP3 as a novel oncogene in papillary thyroid carcinoma.

Wang QX, Chen ED, Cai YF, Zhou YL, Zheng ZC, Wang YH, Jin YX, Jin WX, Zhang XH, Wang OC. Wang QX, et al. Among authors: zhou yl. Onco Targets Ther. 2016 Nov 18;9:7161-7167. doi: 10.2147/OTT.S115668. eCollection 2016. Onco Targets Ther. 2016. PMID: 27920554 Free PMC article.

8

CLDN10 is Associated with Papillary Thyroid Cancer Progression.

Zhou Y, Xiang J, Bhandari A, Guan Y, Xia E, Zhou X, Wang Y, Wang O. Zhou Y, et al. J Cancer. 2018 Nov 25;9(24):4712-4717. doi: 10.7150/jca.28636. eCollection 2018. J Cancer. 2018. PMID: 30588256 Free PMC article.

9

Serum deprivation response functions as a tumor suppressor gene in papillary thyroid cancer.

Wang QX, Chen ED, Cai YF, Zhou YL, Dong SY, Zhang XH, Wang OC, Li Q. Wang QX, et al. Among authors: zhou yl. Clin Genet. 2019 Nov;96(5):418-428. doi: 10.1111/cge.13609. Epub 2019 Jul 31. Clin Genet. 2019. PMID: 31334828

10

Downregulated CDH3 decreases proliferation, migration, and invasion in thyroid cancer.

Zhou Y, Chi Y, Bhandari A, Xia E, Thakur PC, Qu J, Wang O, Zhang X. Zhou Y, et al. Am J Transl Res. 2020 Jun 15;12(6):3057-3067. eCollection 2020. Am J Transl Res. 2020. PMID: 32655830 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

945 results

Search Page

Filters